Table 2.

Correlation of Tyro3TK expression on monocyte subsets with RA patient clinical and immunological features

Features	Tyro3TK on CD14+CD16+ monocytes		Tyro3TK on CD14+CD16− monocytes
	r	P	r	P
Age	− 0.005	0.974	0.071	0.664
Duration	− 0.077	0.637	− 0.071	0.664
WBC	0.15	0.357	0.097	0.554
RBC	0.03	0.853	0.041	0.803
Hb	− 0.023	0.889	0.035	0.831
PLT	0.092	0.572	− 0.012	0.941
ESR	0.088	0.59	0.104	0.522
CRP	0.118	0.469	0.072	0.659
IgA	0.222	0.169	0.196	0.225
IgG	0.106	0.52	0.099	0.547
IgM	0.348*	0.028	0.432**	0.005
RF	0.136	0.402	0.108	0.509
Anti-CCP antibody	0.192	0.243	0.172	0.295
TJC	0.459**	0.003	0.514**	0.001
SJC	0.054	0.741	0.043	0.793
DAS28-ESR	0.28	0.08	0.323*	0.042

The date was analyzed by Spearman’s correlation coefficient test

WBC white blood cells, RBC red blood cells, Hb hemoglobin, PLT platelets, ESR erythrocyte sedimentation rate, CRP C-reactive protein, IgA/G/M immunoglobulin A/G/M, RF rheumatoid factor, Anti-CCP antibody anti-cyclic citrullinated peptide antibody, TJC tender joint count, SJC swollen joint count, DAS Disease Activity Score

*P < 0.05

**P < 0.01